Delivery Order SPE2DB22D3501-SPE2DB25FVH17
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $36,199.65 and is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML medical products. The contract is a firm fixed-price delivery order, with a period of performance running through February 10, 2025. AmerisourceBergen is the prime contractor on...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,917.07, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,632.69 Firm Fixed Price Delivery Order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has an ultimate completion date of March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,765.98, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of July 3, 2024. The contract is not designated with any set-aside requirements, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,374.03, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a prescription medication, with a ceiling value of $10,627.36 and a performance period ending on May 6, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,974.59, is for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $25,549.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication BIMZELX 160 MG/ML AUTOINJECTORML, with a performance period ending on May 2, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,588.45, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIMZELX 320 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $23,436.63 and a period of performance through May 6, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...